Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Fenfluramine hydrochloride

EU orphan designation number: EU/3/13/1219   
Active ingredient: Fenfluramine hydrochloride
Indication: Treatment of Dravet syndrome
Sponsor: Zogenix International Ltd
Siena Court, Broadway, Maidenhead SL6 1NJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/01/2014 Orphan designation EMA/OD/140/13 (2013)9709 of 18/12/2013
16/12/2015 Change of name and/or address of sponsor